Point: Does the Risk of Cross Infection Warrant Exclusion of Adults with Cystic Fibrosis from Cystic Fibrosis Foundation Events? Yes
Overview
Affiliations
Current infection control practices used in Australian and New Zealand cystic fibrosis centers.
Stockwell R, Wood M, Ballard E, Moore V, Wainwright C, Bell S BMC Pulm Med. 2020; 20(1):16.
PMID: 31952502 PMC: 6969421. DOI: 10.1186/s12890-020-1052-y.
Reply to Zuckerman and Saiman: Use of Masks in Patients with Cystic Fibrosis.
Wood M, Stockwell R, Bell S Am J Respir Crit Care Med. 2018; 198(12):1589-1590.
PMID: 30235006 PMC: 7212799. DOI: 10.1164/rccm.201808-1476LE.
Brazilian guidelines for the diagnosis and treatment of cystic fibrosis.
Athanazio R, Silva Filho L, Vergara A, Ribeiro A, Riedi C, Procianoy E J Bras Pneumol. 2017; 43(3):219-245.
PMID: 28746534 PMC: 5687954. DOI: 10.1590/S1806-37562017000000065.
Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis.
Knibbs L, Johnson G, Kidd T, Cheney J, Grimwood K, Kattenbelt J Thorax. 2014; 69(8):740-5.
PMID: 24743559 PMC: 4112489. DOI: 10.1136/thoraxjnl-2014-205213.